These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 380855

  • 1. The kinetics and quality of acquired resistance in self-healing and metastatic leishmaniasis.
    Poulter LW.
    Clin Exp Immunol; 1979 Apr; 36(1):30-7. PubMed ID: 380855
    [Abstract] [Full Text] [Related]

  • 2. The quantification of viable Leishmania enriettii from infected guinea-pig tissues.
    Poulter LW.
    Clin Exp Immunol; 1979 Apr; 36(1):24-9. PubMed ID: 466861
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of immunity to leishmaniasis. II. Significance of the intramacrophage localization of the parasite.
    Poulter LW.
    Clin Exp Immunol; 1980 Apr; 40(1):25-35. PubMed ID: 7389216
    [Abstract] [Full Text] [Related]

  • 4. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA.
    J Immunol; 1989 Jul 01; 143(1):266-74. PubMed ID: 2499629
    [Abstract] [Full Text] [Related]

  • 5. Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide.
    Belehu A, Poulter LW, Turk JL.
    Clin Exp Immunol; 1976 Apr 01; 24(1):125-32. PubMed ID: 949870
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.
    Behin R, Mauel J, Rowe DS.
    Clin Exp Immunol; 1977 Aug 01; 29(2):320-5. PubMed ID: 908177
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages.
    Mauel J, Behin R, Biroum-Noerjasin, Rowe DS.
    Clin Exp Immunol; 1975 May 01; 20(2):339-50. PubMed ID: 813928
    [Abstract] [Full Text] [Related]

  • 8. Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta).
    Porrozzi R, Teva A, Amaral VF, Santos da Costa MV, Grimaldi G.
    Am J Trop Med Hyg; 2004 Sep 01; 71(3):297-305. PubMed ID: 15381810
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of immunity to leishmaniasis. I. Evidence for a changing basis of protection in self-limiting disease.
    Poulter LW.
    Clin Exp Immunol; 1980 Jan 01; 39(1):14-26. PubMed ID: 7389189
    [Abstract] [Full Text] [Related]

  • 10. [Feline leishmaniasis: what's the epidemiological role of the cat?].
    Mancianti F.
    Parassitologia; 2004 Jun 01; 46(1-2):203-6. PubMed ID: 15305717
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of immunity to leishmaniasis III. The development and decay of resistance during metastatic disease.
    Poulter LW, Pearce MT.
    Clin Exp Immunol; 1980 Nov 01; 42(2):211-8. PubMed ID: 6970636
    [Abstract] [Full Text] [Related]

  • 12. Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii.
    Bryceson AD, Bray RS, Dumonde DC.
    Clin Exp Immunol; 1974 Feb 01; 16(2):189-202. PubMed ID: 4619877
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. II. Selective destruction of different Leishmania species in activated guinea-pig and mouse macrophages.
    Behin R, Mauel J, Biroum-Noerjasin, Rowe DS.
    Clin Exp Immunol; 1975 May 01; 20(2):351-8. PubMed ID: 765014
    [Abstract] [Full Text] [Related]

  • 14. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.
    Preston PM, Dumonde DC.
    Clin Exp Immunol; 1976 Jan 01; 23(1):126-38. PubMed ID: 1261086
    [Abstract] [Full Text] [Related]

  • 15. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 01; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 16. Establishment of cutaneous Leishmania enriettii infection in hamsters.
    Belehu A, Turk JL.
    Infect Immun; 1976 Apr 01; 13(4):1235-41. PubMed ID: 1279005
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
    Menon JN, Bretscher PA.
    Eur J Immunol; 1996 Jan 01; 26(1):243-9. PubMed ID: 8566074
    [Abstract] [Full Text] [Related]

  • 18. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL, Berger M, Nacy CA, Hockmeyer WT, Meltzer MS.
    J Immunol; 1984 Feb 01; 132(2):893-7. PubMed ID: 6690622
    [Abstract] [Full Text] [Related]

  • 19. [Indices of the state of the T-system of immunity in experimental cutaneous leishmaniasis in guinea pigs].
    Konovalova SA.
    Med Parazitol (Mosk); 1981 Feb 01; 50(6):23-7. PubMed ID: 6976505
    [No Abstract] [Full Text] [Related]

  • 20. Resistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection.
    Hill JO.
    Infect Immun; 1984 Jul 01; 45(1):127-32. PubMed ID: 6735464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.